 Pergolide
"Pergolide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES.
| Descriptor ID |
D010479
|
| MeSH Number(s) |
D03.132.327.287.800 D03.549.439.800
|
| Concept/Terms |
Pharken- Pharken
- Elanco Brand of Pergolide Mesylate
Permax- Permax
- Celance
- Parkotil
- Lilly Brand of Pergolide
- Lilly Brand of Pergolide Mesylate
- Athena Brand of Pergolide Mesylate
- Draxis Brand of Pergolide Mesylate
LY-127809- LY-127809
- LY127809
- LY-127,809
- LY127,809
|
Below are MeSH descriptors whose meaning is more general than "Pergolide".
Below are MeSH descriptors whose meaning is more specific than "Pergolide".
This graph shows the total number of publications written about "Pergolide" by people in this website by year, and whether "Pergolide" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1982 | 0 | 1 | 1 | | 1983 | 0 | 2 | 2 | | 1985 | 0 | 2 | 2 | | 1987 | 1 | 0 | 1 | | 1989 | 0 | 1 | 1 | | 1990 | 0 | 1 | 1 | | 1992 | 0 | 1 | 1 | | 1993 | 0 | 1 | 1 | | 2000 | 1 | 0 | 1 | | 2005 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pergolide" by people in Profiles.
-
Goetz CG, Poewe W, Rascol O, Sampaio C. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord. 2005 May; 20(5):523-39.
-
Comella CL, Morrissey M, Janko K. Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Neurology. 2005 Apr 26; 64(8):1450-1.
-
Kujawa K, Leurgans S, Raman R, Blasucci L, Goetz CG. Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Arch Neurol. 2000 Oct; 57(10):1461-3.
-
Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol. 1993 Nov; 34(5):710-4.
-
Goetz CG, Diederich NJ. Dopaminergic agonists in the treatment of Parkinson's disease. Neurol Clin. 1992 May; 10(2):527-40.
-
Goetz CG. Dopaminergic agonists in the treatment of Parkinson's disease. Neurology. 1990 Oct; 40(10 Suppl 3):suppl 50-4; discussion 54-7.
-
Goetz CG, Shannon KM, Tanner CM, Carroll VS, Klawans HL. Agonist substitution in advanced Parkinson's disease. Neurology. 1989 Aug; 39(8):1121-2.
-
Tanner CM, Goetz CG, Glantz RH, Klawans HL. Pergolide mesylate: four years experience in Parkinson's disease. Adv Neurol. 1987; 45:547-9.
-
Tanner CM, Chhablani R, Goetz CG, Klawans HL. Pergolide mesylate: lack of cardiac toxicity in patients with cardiac disease. Neurology. 1985 Jun; 35(6):918-21.
-
Goetz CG, Tanner CM, Glantz RH, Klawans HL. Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide. Neurology. 1985 May; 35(5):749-51.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|